Jazz, Concert to Explore Formulation Options for JZP-386
Jazz Pharmaceuticals plc and Concert Pharmaceuticals Inc have completed Phase 1 clinical study of JZP-386, a deuterium-containing analog of sodium oxybate. The Phase 1 study evaluated the safety, pharmacokinetics, and...
Read More